ASIC Puts A Hold On Cryptocurrency Promoters

The Australian Securities and Investments Commission (ASIC) is a corporate regulator which protects the interest of consumers, investors and creditors via regulation of companies and financial services laws in Australia. To tighten the stance on the risky investments, the regulator is taking series of actions to stop various Initial Coin Offerings (ICO) from pitching to retail investors in terms of raising capital. ASIC have put a hold on many ICO’s since April. In the past, ASIC has warned that many ICO’s are not following Australian law and many have turned out to be scams. ASIC is making sure that these ICO’s are complying with the Australia’s Law before reaching out to retail investors. ASIC is open for new financial innovations but not at the expense of basic consumer protection.

New Dawn Fund was recently stopped to issue its product disclosure statement which was issued by Investor exchange limited after ASIC’s concerns. The fund was proposing to invest in various types of cryptocurrency assets. According to ASIC, there are several problems with Initial coin offerings and funds that invest in Crypto-assets. These ICO’s and funds are using misleading or deceptive statements in marketing and sales material. Also, there are various unregistered, illegal management schemes which are operated by ICO’s. Many ICO’s are not the holder of Australian Financial services License. [optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

While this is coming under an enforcement plan, the cryptocurrency scenario has taken a toll at many geographies overall. Its not even 24 hours that we saw cryptocurrency trying to rebound with support coming from prices of ripple (up about 18%) while Bitcoin moved up about 1%.

On one hand ripple was getting a boost from news on commercial application of a crypto-driven product to be launched soon; and on the other, we had ICOs in Australia coming under pressure by ASIC.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.


Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report